Please login to the form below

Not currently logged in

Cynapsus Therapeutics

This page shows the latest Cynapsus Therapeutics news and features for those working in and with pharma, biotech and healthcare.

Michael J Fox Foundation backs wearable device trial

Michael J Fox Foundation backs wearable device trial

Michael J Fox Foundation backs wearable device trial. Partners with chip manufacturer Intel and Cynapsus Therapeutics on Parkinson's study. ... Trials of a new therapy for Parkinson's disease developed by Cynapsus Therapeutics will use a smartwatch-like

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Deal Watch September 2016 Deal Watch September 2016

    Adaptimmune Therapeutics entered into a collaboration with MD Anderson Cancer Center to develop specific peptide-enhanced affinity receptor T cell immunotherapies in solid and haematological cancers. ... 639. Cynapsus Therapeutics / Sunovion. Acquisition

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts


Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...